Related Experiment Video
Updated: Jun 27, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Radiological Features for Predicting the Status of CD8-Positive Lymphocytes in HER2 Positive Breast Cancer
Yuhong Fan1, Xiaoguang Li2, Peng Zhong3
1Department of Ultrasound Diagnosis, Daping Hospital, Army Medical University, Chongqing, China.
Ultrasound and MRI features, specifically shape, orientation, posterior echo, and apparent diffusion coefficient (ADC), can predict CD8-positive tumor-infiltrating lymphocytes (TILs) in HER2-positive breast cancer. Combining these imaging features improves prediction accuracy for guiding clinical decisions.
Area of Science:
- Oncology
- Radiology
- Immunology
Background:
- Tumor-infiltrating lymphocytes (TILs) are crucial in HER2-positive breast cancer prognosis.
- Higher TILs correlate with better pathological complete response to treatment.
Purpose of the Study:
- To explore the association between ultrasound (US) and MRI features and CD8-positive TIL levels in HER2-positive breast cancer.
- To identify imaging biomarkers for predicting CD8-positive TIL status.
Main Methods:
- Retrospective study of 155 women with HER2-positive breast cancer.
- US and MRI features evaluated using BI-RADS lexicon; apparent diffusion coefficient (ADC) calculated.
- Multivariate analysis and ROC analysis to determine predictive performance of imaging features.
Main Results:
- US features (shape, orientation, posterior echo) and MRI ADC were independent predictors of CD8-positive TIL levels.
- US features achieved an AUC of 0.802; ADC achieved an AUC of 0.705.
- Combined US and ADC showed superior predictive efficacy (AUC = 0.888) compared to individual modalities.
Conclusions:
- US features and ADC value are valuable tools for estimating CD8-positive TIL levels in HER2-positive breast cancer.
- A predictive nomogram incorporating these features can aid clinical decision-making.
More Related Videos
11:31Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
Published on: August 8, 2012
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023